From Wikipedia, the free encyclopedia
Jump to: navigation, search
Minicircle preparation from a parental plasmid. The parental plasmid contains two recombinase target sites (black half arrows). Recombination between these sites generates the desired minicircle (bottom right) together with the miniplasmid (bottom left). The hook on the red minicircle-insert stands for a scaffold-matrix attachment region ( S/MAR-Element), which allows for autonomous replication in the recipient cell.

Minicircles are small (~4kb) circular plasmid derivatives that have been freed from all prokaryotic vector parts. They have been applied as transgene carriers for the genetic modification of mammalian cells, with the advantage that, since they contain no bacterial DNA sequences, they are less likely to be perceived as foreign and destroyed. (Typical transgene delivery methods involve plasmids, which contain foreign DNA.) The smaller size of minicircles also extends their cloning capacity and facilitates their delivery into cells.

Their preparation usually follows a two-step procedure:[1][2]

  • production of a 'parental plasmid' (bacterial plasmid with eukaryotic inserts) in E. coli
  • induction of a site-specific recombinase at the end of this process but still in bacteria. These steps are followed by the
    • excision of prokaryotic vector parts via two recombinase-target sequences at both ends of the insert
    • recovery of the resulting minicircle (vehicle for the highly efficient modification of the recipient cell) and the miniplasmid by capillary gel electrophoresis (CGE)

The purified minicircle can be transferred into the recipient cell by transfection or lipofection and into a differentiated tissue by, for instance, jet injection.

Conventional minicircles lack an origin of replication, so they do not replicate within the target cells and the encoded genes will disappear as the cell divides (which can be either an advantage or disadvantage depending on whether the application demands persistent or transient expression). A novel addition to the field are nonviral self-replicating minicircles, which owe this property to the presence of a S/MAR-Element. Self-replicating minicircles hold great promise for the systematic modification of stem cells and will significantly extend the potential of their plasmidal precursor forms ("parental plasmids"), the more as the principal feasibility of such an approach has amply been demonstrated for their plasmidal precursor forms.[3][4][5][6]

See also[edit]


  1. ^ Nehlsen, K., Broll S., Bode, J. (2006). "Replicating minicircles: Generation of nonviral episomes for the efficient modification of dividing cells". Gene Ther. Mol. Biol. 10: 233–244. 
  2. ^ Kay, M.A., He, C.-Y, Chen, Z.-H. (2010). "A robust system for production of minicircle DNA vectors". Nature Biotechnology. 28: 1287–1289. PMC 4144359Freely accessible. PMID 21102455. doi:10.1038/nbt.1708. 
  3. ^ Broll, S., Oumard A., Hahn K., Schambach A, Bode, J. . (2010). "Minicircle Performance Depending on S/MAR-Nuclear Matrix Interactions". J. Mol. Biol. 395: 950–965. PMID 20004666. doi:10.1016/j.jmb.2009.11.066. 
  4. ^ Argyros, O., Wong SP., Fedonidis C.; et al. (2011). "Development of S/MAR minicircles for enhanced and persistent transgene expression in the mouse liver". J. Mol. Med. 89: 515–529. doi:10.1007/s00109-010-0713-3. 
  5. ^ Heinz, N, Broll S, Schleef M, Baum C, Bode J (2012). "Filling a gap: S/MAR-based replicating minicircles". CliniBook - Nonviral Platform; Clinigene Network: 271–277. 
  6. ^ Nehlsen, S, Broll S, Kandimalla R, Heinz N, Heine M, Binius S, Schambach A & Bode J (2013). "Replicating Minicircles: Overcoming the limitations of transient and of stable expression systems". Minicircle and Plasmid DNA Vectors - The Future of non-viral and viral Gene-Transfer, Schleef, M. (ed.), ISBN 978-3-527-32456-9 - Wiley-VCH, Weinheim: 115–162.